Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

180
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
180
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

564
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
564

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical outcomes of hypertriglyceridemia-associated acute pancreatitis: a prospective multicenter Italian cohort.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2026
Same author

Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterization.

International journal of cancer·2024
Same author

Potential association between PSCA rs2976395 functional variant and pancreatic cancer risk.

International journal of cancer·2024
Same author

A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma.

Mutagenesis·2024
Same author

Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk.

Human genomics·2024
Same author

Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer.

The American journal of gastroenterology·2023

Related Experiment Video

Updated: Nov 19, 2025

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens
10:38

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens

Published on: February 1, 2020

7.7K

[Screening protocols for pancreatic cancer.]

Raffaele Pezzilli1

  • 1Unità Operativa Complessa di Medicina Interna, Ospedale San Carlo, Potenza.

Recenti Progressi in Medicina
|January 29, 2021
PubMed
Summary

Pancreatic cancer is a deadly disease with low survival rates due to late diagnosis. This review explores screening programs to enable early detection and improve outcomes for this silent killer.

Area of Science:

  • Oncology
  • Gastroenterology
  • Preventive Medicine

Background:

  • Pancreatic cancer is a highly aggressive malignancy, ranking as a leading cause of cancer death globally.
  • Low survival rates (9% at 5 years) are attributed to late-stage diagnosis, as symptoms often appear only when the disease is advanced.
  • Despite treatment advances, over 80% of patients are diagnosed at advanced stages, highlighting the need for early detection strategies.

Purpose of the Study:

  • To review the current literature on the feasibility and existence of screening programs for pancreatic cancer.
  • To identify potential strategies for the prevention, early diagnosis, and treatment of pancreatic cancer.
  • To address the challenge of diagnosing pancreatic cancer at an early, treatable stage.

Main Methods:

More Related Videos

Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique
13:56

Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique

Published on: August 14, 2021

6.8K
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.7K

Related Experiment Videos

Last Updated: Nov 19, 2025

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens
10:38

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens

Published on: February 1, 2020

7.7K
Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique
13:56

Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique

Published on: August 14, 2021

6.8K
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.7K
  • Systematic literature review of existing studies on pancreatic cancer screening.
  • Analysis of current diagnostic and therapeutic approaches for pancreatic cancer.
  • Evaluation of the effectiveness of screening programs in at-risk populations.

    • Main Results:

    • Pancreatic cancer is projected to become the second leading cause of cancer death by 2030.
    • Current screening methods and programs for pancreatic cancer are limited.
    • Early diagnosis remains a critical unmet need in managing pancreatic cancer.

    Conclusions:

    • Effective screening programs are essential for improving pancreatic cancer survival rates.
    • Further research is needed to develop and implement reliable screening strategies.
    • Proactive screening in high-risk individuals is crucial for early detection and intervention.